merck
German Chancellor Olaf Scholz pledged further government backing for the pharmaceutical industry and touted recent investments in the country. Scholz spoke at the laying of the foundation stone on Thursday for a €300 million ($320 million) new research centre at German chemical and pharmaceutical firm Merck's headquarters in the western German city of Darmstadt, located south of Frankfurt. The chancellor called the expansion project a "commitment to Germany as a strong location for pharmaceuticals, industry and research." The centre is scheduled to open in three years. "Investments such as tho...
DPA Breaking News
German Chancellor Olaf Scholz pledged further government backing for the pharmaceutical industry and touted recent investments in the country. Scholz spoke at the laying of the foundation stone on Thursday for a €300 million ($320 million) new research centre at German chemical and pharmaceutical firm Merck's headquarters in the western German city of Darmstadt, located south of Frankfurt. The chancellor called the expansion project a "commitment to Germany as a strong location for pharmaceuticals, industry and research." The centre is scheduled to open in three years. "Investments such as tho...
DPA International
German Chancellor Olaf Scholz pledged further government backing for the pharmaceutical industry and touted recent investments in the country. Scholz spoke at the laying of the foundation stone on Thursday for a €300 million ($320 million) new research centre at German chemical and pharmaceutical firm Merck's headquarters in the western German city of Darmstadt, located south of Frankfurt. The chancellor called the expansion project a "commitment to Germany as a strong location for pharmaceuticals, industry and research." The centre is scheduled to open in three years. "Investments such as tho...
DPA
Bundeskanzler Olaf Scholz hat der deutschen Pharmaindustrie weitere Unterstützung zugesichert. Anlässlich der Grundsteinlegung für ein neues Forschungszentrum von Merck, in das der Pharma- und Chemiekonzern mehr als 300 Millionen Euro investiert, sprach Scholz von einem «Bekenntnis zu Deutschland als starkem Pharma-, Industrie- und Forschungsstandort». Investitionen wie diese seien bei weitem nicht die Einzigen, sagte Scholz in Darmstadt. So baue der US-Pharma-Konzern Eli Lilly in Rheinland-Pfalz für 2,3 Milliarden Euro ein neues Werk und die Pharmaunternehmen Roche aus der Schweiz sowie Daiic...
DPA (German)
German pharmaceutical and chemical company Merck is investing more than €300 million ($320 million) in a new research centre at its headquarters in the western German city of Darmstadt south of Frankfurt. German Chancellor Olaf Scholz spoke at the laying of the foundation stone for the expansion on Thursday, calling it a "commitment to Germany as a strong location for pharmaceuticals, industry and research." The centre is scheduled to open in three years. "Investments such as those made by Merck here at the Darmstadt headquarters make exceptional economic, medical and scientific sense," said S...
DPA
German pharmaceutical and chemical company Merck is investing more than €300 million ($320 million) in a new research centre at its headquarters in the western German city of Darmstadt south of Frankfurt. German Chancellor Olaf Scholz spoke at the laying of the foundation stone for the expansion on Thursday, calling it a "commitment to Germany as a strong location for pharmaceuticals, industry and research." The centre is scheduled to open in three years. "Investments such as those made by Merck here at the Darmstadt headquarters make exceptional economic, medical and scientific sense," said S...
DPA International
German pharmaceutical and chemical company Merck is investing more than €300 million ($320 million) in a new research centre at its headquarters in the western German city of Darmstadt south of Frankfurt. German Chancellor Olaf Scholz spoke at the laying of the foundation stone for the expansion on Thursday, calling it a "commitment to Germany as a strong location for pharmaceuticals, industry and research." The centre is scheduled to open in three years. "Investments such as those made by Merck here at the Darmstadt headquarters make exceptional economic, medical and scientific sense," said S...
DPA Breaking News
Corona-Boom vorbei, Gegenwind im Geschäft mit Halbleitermaterialien für Elektrogeräte: Nach einem deutlichen Gewinnrückgang 2023 setzt der Darmstädter Pharma- und Spezialchemiekonzern Merck auf die Wende in diesem Jahr. Das Dax-Unternehmen fokussiere sich auf die «schrittweise Rückkehr zu Wachstum im Laufe des Geschäftsjahrs 2024», sagte Vorstandschefin Belen Garijo bei der Bilanzvorlage am Donnerstag. 2023 bezeichnete sie als Übergangsjahr: Merck kämpfte mit einem Nachfrageeinbruch im Laborgeschäft, das in der Corona-Pandemie noch dank großer Nachfrage von Impfstoffherstellern floriert hatte....
DPA (German)
German science and technology major Merck KgaA reported on Thursday that its fiscal 2023 profit after tax fell 15.1% to €2.83 billion ($3.08 billion) from last year's €3.34 billion. Earnings per share were €6.49, down 15.2% from last year's €7.65. On an adjusted basis, earnings per share pre were €8.49, compared to last year's €10.05. EBITDA pre fell 14.2% year-over-year to €5.88 billion, EBITDA margin pre dropped to 28% from 30.8% last year. Net sales for the year declined 5.6% to €20.99 billion from €22.23 billion a year ago. Group net sales decreased 1.6% organically. Further, the Executive...
DPA
German science and technology major Merck KgaA reported on Thursday that its fiscal 2023 profit after tax fell 15.1% to €2.83 billion ($3.08 billion) from last year's €3.34 billion. Earnings per share were €6.49, down 15.2% from last year's €7.65. On an adjusted basis, earnings per share pre were €8.49, compared to last year's €10.05. EBITDA pre fell 14.2% year-over-year to €5.88 billion, EBITDA margin pre dropped to 28% from 30.8% last year. Net sales for the year declined 5.6% to €20.99 billion from €22.23 billion a year ago. Group net sales decreased 1.6% organically. Further, the Executive...
DPA International
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら